Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters











Publication year range
1.
Death Stud ; 46(6): 1490-1500, 2022.
Article in English | MEDLINE | ID: mdl-33750278

ABSTRACT

Advances in perinatal medicine, present increasing numbers of women with difficult decisions about their pregnancy. We explored the views of 5 parents and 5 perinatal healthcare professionals regarding late termination of pregnancy following the principles of qualitative content analysis. Parents deciding on whether to (dis)continue pregnancy needed more time and decisional support. Decentralized care and lacking continuity between caregivers led to negative experiences. No standardized bereavement services were offered after leaving the hospital. Integrating principles of perinatal palliative care to care might help to offer further decisional support and to overcome the fragmentation of care.


Subject(s)
Bereavement , Perinatal Death , Child , Female , Grief , Humans , Infant, Newborn , Loneliness , Parents , Perinatal Care , Pregnancy , Qualitative Research
3.
Am J Clin Nutr ; 61(6): 1290-4, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7762533

ABSTRACT

The visceral and subcutaneous abdominal adipose tissue (AT) area and the subcutaneous hip AT area were assessed by magnetic resonance imaging (MRI) in 12 growth hormone-deficient adults before and after 6 mo of replacement with recombinant human growth hormone (rhGH) and in 12 healthy control subjects. The data obtained by MRI were compared with circumference measurements of waist and hip. Growth hormone-deficient patients compared with control subjects had a higher visceral AT area (P = 0.003) and subcutaneous AT area (P = 0.013); there was no significant difference in subcutaneous hip AT area. Six months of rhGH replacement reduced the subcutaneous hip AT area (19.8%), the subcutaneous abdominal AT area (15.6%), and particularly the visceral AT area (38.2%), resulting in fat areas that were not different from those of control subjects. Furthermore, this study shows that in contrast with control subjects, circumference measurements are not useful to predict AT areas in growth hormone-deficient patients and cannot be used to assess changes in AT areas during rhGH replacement.


Subject(s)
Adipose Tissue/drug effects , Growth Hormone/deficiency , Growth Hormone/pharmacology , Adipose Tissue/anatomy & histology , Adult , Anthropometry , Body Composition , Double-Blind Method , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged
4.
Neuroradiology ; 36(1): 59-62, 1994.
Article in English | MEDLINE | ID: mdl-8108001

ABSTRACT

To evaluate the effectiveness of CT and MRI at 0.5 T in the diagnosis and staging of retinoblastoma, we studied 11 patients in whom retinoblastoma was clinically suspected. Nine of the eleven had surgically proven retinoblastoma; in the other two a diagnosis of Coats' disease was made. MRI was not as specific as CT for diagnosing retinoblastoma, due to its lack of sensitivity in detecting calcification; it did, however, have superior contrast resolution. On MRI, Coats' disease was reliably diagnosed and easily differentiated from retinoblastoma. Moreover, the greater ability of MRI to differentiate subretinal fluid from tumour also confers high accuracy in measuring tumour size. CT is still the study of choice in the diagnosis of retinoblastoma, but when MRI is available, it should be performed for better differentiation from lesions such as Coats' disease.


Subject(s)
Eye Neoplasms/diagnosis , Magnetic Resonance Imaging , Retinoblastoma/diagnosis , Tomography, X-Ray Computed , Child , Child, Preschool , Diagnosis, Differential , Eye Neoplasms/diagnostic imaging , Female , Humans , Infant , Male , Retinal Diseases/diagnosis , Retinal Diseases/diagnostic imaging , Retinoblastoma/diagnostic imaging , Sensitivity and Specificity
5.
Can J Neurol Sci ; 17(1): 71-3, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2311021

ABSTRACT

Nineteen patients, seven women and twelve men, with macroprolactinomas characterized by extrasellar extension and basal prolactin levels above 6 U/l were treated with 10-20 mg bromocriptine daily in four divided doses for a mean period of 3.4 years (range 1.5-5.5 years). Plasma prolactin levels fell dramatically in all patients and values in the low normal range were obtained in sixteen patients. Tumor size was reduced by more than 75% in seventeen patients and by 50-75% in two patients. Tumor reduction was associated with the development of a partial empty sella in fourteen cases. In seventeen cases the pituitary became visible. Diminished visual acuity (six patients), bitemporal hemianopia (nine patients), unilateral and bilateral central scotomas (three patients) and oculomotor palsy (two patients) improved or normalized in all cases. Hypogonadism (all patients), hypothyroidism (nine patients) and hypocorticism (four patients) improved or normalized in most cases. It is concluded that in the medical treatment of macroprolactinomas 10-20 mg bromocriptine in four divided doses effectively reduces both plasma prolactin level and tumor size. The good results in this study may be related to the continued use of a fixed dose regimen of bromocriptine regardless of the plasma prolactin lowering effect.


Subject(s)
Bromocriptine/therapeutic use , Pituitary Neoplasms/drug therapy , Prolactinoma/drug therapy , Female , Humans , Male , Pituitary Neoplasms/blood , Pituitary Neoplasms/metabolism , Prolactin/blood , Prolactinoma/blood
6.
Neth J Med ; 35(1-2): 95-9, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2779697

ABSTRACT

The case history is presented of a woman with secondary amenorrhoea, mild hyperprolactinaemia and pituitary enlargement with suprasellar extension, mimicking a pituitary adenoma. It appeared that she had primary hypothyroidism. After L-thyroxine treatment, all abnormalities disappeared. The literature on the combination of primary hypothyroidism, hyperprolactinaemia and pituitary enlargement is reviewed and the pathophysiology is discussed. It is concluded that determination of thyrotropin is essential in all patients with pituitary enlargement and hyperprolactinaemia.


Subject(s)
Adenoma/complications , Hypothyroidism/etiology , Pituitary Neoplasms/complications , Adult , Diagnosis, Differential , Female , Humans
7.
Acta Endocrinol (Copenh) ; 119(1): 51-5, 1988 Sep.
Article in English | MEDLINE | ID: mdl-3414319

ABSTRACT

Five patients, 3 women and 2 men, with macroprolactinomas characterized by extrasellar extension and basal plasma prolactin levels ranging from 4.6 to 102 U/l received six monthly injections of 50-100 mg Parlodel LAR, an injectable long-acting repeatable form of bromocriptine. The following observations were made: 1. Plasma prolactin levels fell dramatically in all patients and values in the normal range were obtained in 3 patients. 2. In all patients, the onset of tumour reduction was visible on CT scans made one week after the first Parlodel LAR injection. After six Parlodel LAR injections, tumour size was reduced by more than 75% in 3 patients and by 50-75% in two patients. 3. Diminished visual acuity (one patient), bitemporal hemianopia (2 patients), and oculomotor and trochlear nerve dysfunction (one patient) were restored to normal after the first Parlodel LAR injection. 4. Hypogonadism normalized in 2 patients and improved in one patient, whereas plasma gonadotropins remained low in the 2 postmenopausal women. In one patient with hypothyroidism and hypocorticism, thyroid and adrenal functions normalized. It is concluded that bromocriptine retard (50-100 mg monthly) is a useful alternative for oral treatment of patients with prolactinomas, especially in those patients with compliance problems on oral bromocriptine therapy.


Subject(s)
Adenoma/drug therapy , Bromocriptine/administration & dosage , Pituitary Neoplasms/drug therapy , Prolactin/metabolism , Adenoma/diagnostic imaging , Adenoma/metabolism , Adolescent , Adult , Aged , Bromocriptine/adverse effects , Delayed-Action Preparations , Female , Humans , Male , Middle Aged , Pituitary Neoplasms/diagnostic imaging , Pituitary Neoplasms/metabolism , Tomography, X-Ray Computed , Visual Acuity/drug effects
9.
Acta Endocrinol (Copenh) ; 117(2): 154-8, 1988 Feb.
Article in English | MEDLINE | ID: mdl-3381631

ABSTRACT

Twenty-five patients with acromegaly were treated by transsphenoidal microsurgery. Fourteen patients (56%) were considered cured according to the following criteria: a. basal plasma GH less than 10 mU/l; b. glucose suppressed plasma GH less than or equal to 4 mU/l, and c. disappearance of TRH responsiveness if present preoperatively. Thirteen of the cured patients were re-evaluated after a mean follow-up period of 3.5 years (range 1.5 to 5.5 years). At that time, basal plasma GH was still less than 10 mU/l and glucose suppressed plasma GH was still less than or equal to 4 mU/l in all patients, indicating the practical value of our criteria. The remaining 11 patients (44%) received additional treatment by external pituitary irradiation and bromocriptine. Owing to surgery, 5 patients (20%) developed partial or panhypopituitarism.


Subject(s)
Acromegaly/therapy , Adenoma/surgery , Microsurgery/methods , Pituitary Neoplasms/surgery , Acromegaly/blood , Adult , Aged , Female , Follow-Up Studies , Growth Hormone/blood , Humans , Male , Middle Aged , Postoperative Complications
10.
Gastrointest Radiol ; 12(2): 121-7, 1987.
Article in English | MEDLINE | ID: mdl-3556971

ABSTRACT

Computed tomographic (CT) findings in 105 cases of pancreatitis and 107 cases of pancreatic carcinoma were analyzed retrospectively to determine the occurrence and roentgenologic signs of penetration of the anterior renal fascial planes in relation to clinical symptoms. In pancreatitis, the perirenal fat was infiltrated in 7% to variable extents by extrapancreatic fluid collections, either as asymptomatic fluid lying alongside renal fascial planes and perirenal septa (5 cases) or as well-circumscribed fluid collections causing clinical symptoms (2 cases). In pancreatic carcinoma the occurrence of retropancreatic extension to a perirenal space was rarer (3%). Distinction on CT between perirenal involvement from the pancreas and primary adrenal or renal lesions with anterior spread can prevent unnecessary surgery.


Subject(s)
Adenocarcinoma/diagnostic imaging , Kidney/diagnostic imaging , Pancreatic Neoplasms/diagnostic imaging , Pancreatitis/diagnostic imaging , Adult , Aged , Diagnosis, Differential , Exudates and Transudates/metabolism , Fascia/diagnostic imaging , Female , Follow-Up Studies , Humans , Kidney Diseases/diagnostic imaging , Male , Middle Aged , Pancreas/metabolism , Pancreatic Pseudocyst/diagnostic imaging , Prognosis , Radiography , Retroperitoneal Space/diagnostic imaging , Retrospective Studies
11.
Acta Endocrinol (Copenh) ; 112(4): 487-93, 1986 Aug.
Article in English | MEDLINE | ID: mdl-3751462

ABSTRACT

Twelve patients, six women and six men, with macroprolactinomas characterized by extrasellar extension and basal plasma prolactin levels greater than 6 U/l were treated with 10-20 mg bromocriptine daily in four divided doses for a mean period of 2.4 years (range 0.5-3.5 years). The following observations were made: Plasma prolactin levels fell dramatically in all patients and values in the low normal range were obtained in 10 patients. Tumour size was reduced by more than 75% in 11 patients and by 50-75% in one patient. Tumour-reduction was associated with the development of a partial empty sella in eight cases. In four cases the pituitary became visible. Diminished visual acuity (three patients), bitemporal hemianopia (three patients), unilateral or bilateral central scotomas (three patients) and oculomotor palsy (two patients) restored to normal. Hypogonadism (all patients), hypothyroidism (six patients) and hypocorticism (three patients) improved or normalized in most cases. It is concluded that in the medical treatment of macroprolactinomas 10-20 mg bromocriptine in four divided doses effectively reduces both plasma prolactin level and tumour size.


Subject(s)
Adenoma/metabolism , Bromocriptine/therapeutic use , Pituitary Neoplasms/metabolism , Prolactin/metabolism , Adenoma/diagnosis , Adenoma/drug therapy , Adolescent , Adult , Female , Humans , Hypogonadism/diagnosis , Hypothyroidism/diagnosis , Male , Middle Aged , Pituitary Neoplasms/diagnosis , Pituitary Neoplasms/drug therapy , Tomography, X-Ray Computed , Visual Acuity
12.
Urol Radiol ; 8(2): 85-8, 1986.
Article in English | MEDLINE | ID: mdl-3538607

ABSTRACT

Two cases of diffuse histiocytic lymphoma limited to both adrenals are described. Familiarity with these rare lesions will lead to a proper diagnostic approach.


Subject(s)
Adrenal Gland Neoplasms/pathology , Lymphoma, Non-Hodgkin/pathology , Adrenal Gland Neoplasms/diagnostic imaging , Adult , Angiography , Humans , Lymphoma, Non-Hodgkin/diagnostic imaging , Male , Middle Aged , Tomography, X-Ray Computed , Ultrasonography
14.
Gastrointest Radiol ; 10(4): 370-7, 1985.
Article in English | MEDLINE | ID: mdl-4054506

ABSTRACT

The clinical complications of diverticular disease may be unclear. Seven patients with complicated diverticulitis of the transverse, descending, and sigmoid colon were examined with computed tomography. Exact knowledge of the anatomical relationships of the transverse, descending, and sigmoid colon and neighboring structures are a prerequisite for understanding and interpreting the extensions of peridiverticular disease. Computed tomography proved to be useful in evaluating the presence and extent of sequelae of perforations, and, as a consequence, influenced the planning and timing of treatment.


Subject(s)
Diverticulitis, Colonic/complications , Sigmoid Diseases/complications , Tomography, X-Ray Computed , Abscess/diagnostic imaging , Abscess/etiology , Adult , Aged , Contrast Media , Diverticulitis, Colonic/diagnostic imaging , Female , Humans , Intestinal Fistula/diagnostic imaging , Intestinal Fistula/etiology , Iothalamic Acid/analogs & derivatives , Male , Middle Aged , Sigmoid Diseases/diagnostic imaging
15.
Gastrointest Radiol ; 10(3): 289-95, 1985.
Article in English | MEDLINE | ID: mdl-4029546

ABSTRACT

Due to the position and length of the appendix, intraabdominal abscesses after perforation in complicated acute appendicitis may occur in several different and sometimes unsuspected anatomical locations. Five patients are described with proven complicated acute appendicitis and inflammatory processes in multiple sites: anterior pararenal space, general retroperitoneum, subcutaneous fat space, intraperitoneal cavity, and small bowel mesentery. A confusing case of ileocecal carcinoid with mesenteric involvement is also presented. In all cases complicated acute appendicitis was diagnosed on CT prior to surgery, except in 1 case in which a pelvic abscess developed after intramural cecal bleeding in a patient with hemophilia B.


Subject(s)
Abdomen , Abscess/diagnostic imaging , Appendicitis/diagnostic imaging , Abscess/complications , Acute Disease , Adult , Aged , Appendicitis/complications , Cecal Diseases/diagnostic imaging , Female , Humans , Male , Middle Aged , Peritoneal Diseases/complications , Peritoneal Diseases/diagnostic imaging , Radiography, Abdominal , Retroperitoneal Space/diagnostic imaging , Tomography, X-Ray Computed
16.
Acta Endocrinol (Copenh) ; 107(4): 471-5, 1984 Dec.
Article in English | MEDLINE | ID: mdl-6097074

ABSTRACT

Transfrontal hypophysectomy was performed in a patient with Cushing's disease and gross enlargement of the pituitary. Despite some reduction of cortisol production active Cushing's syndrome remained due to the presence of a tumour remnant. Medical treatment with the GABA-transaminase inhibitor sodium valproate induced hypocorticism necessitating corticosteroid substitution therapy. Nine months after sodium valproate withdrawal hypercorticism was documented. Re-institution of sodium valproate treatment induced hypocorticism again. As sodium valproate is known to induce a decrease of plasma ACTH in Nelson's syndrome, it is proposed that large tumours present at the time of diagnosis and those appearing after adrenalectomy may represent the spectrum of a single disorder. A prospective trial to study the effects of sodium valproate and other neurotransmitter modulating agents on the size and endocrine function of ACTH secreting macroadenomas is urgently needed.


Subject(s)
Adenoma/complications , Cushing Syndrome/drug therapy , Pituitary Neoplasms/complications , Valproic Acid/therapeutic use , 17-Hydroxycorticosteroids/urine , Adenoma/blood , Adrenocorticotropic Hormone/blood , Cushing Syndrome/blood , Cushing Syndrome/complications , Female , Humans , Hydrocortisone/blood , Middle Aged , Pituitary Neoplasms/blood
17.
J Comput Assist Tomogr ; 8(6): 1131-5, 1984 Dec.
Article in English | MEDLINE | ID: mdl-6389622

ABSTRACT

The CT findings in cystic teratomas of the ovary are reviewed and our findings in four patients discussed. We analyzed those teratomas with standard CT, augmented by direct nonreconstructed coronal and sagittal views, to establish the true extent of the process and to define the characteristic heterogeneous contents. Computed tomography was successful in predicting or excluding malignant degeneration.


Subject(s)
Dermoid Cyst/diagnostic imaging , Ovarian Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Adult , Dermoid Cyst/surgery , Female , Humans , Middle Aged , Ovarian Neoplasms/surgery , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL